Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-Jul-24 12:28 PM View:  | Incyte Corp (INCY) | 15-Jul-24 | Grant | 19,851 | -- | -- | 10% 202.07K to 221.92K | |
| 17-Jul-24 12:28 PM View: | Incyte Corp (INCY) | 15-Jul-24 | Payment of Exercise | 749 | $64.25 | $48,123.20 | (< 1%) 221.92K to 221.17K | |
| 18-Jul-23 4:00 PM View: | Incyte Corp (INCY) | 14-Jul-23 | Grant | 9,668 | -- | -- | 5% 192.4K to 202.07K | |
| 07-Jun-23 2:00 PM View: | Incyte Corp (INCY) | 05-Jun-23 | Grant | 179,613 | -- | -- | 100% 0 to 179.61K | |
| 01-Feb-23 9:41 PM View: | Rubius Therapeutics, Inc. (RUBY) | 01-Feb-23 | Sale | 8,448 | $0.25 | $2,112.00 | (11%) 74.53K to 66.08K | |
| 31-Jan-23 9:51 PM View: | Rubius Therapeutics, Inc. (RUBY) | 31-Jan-23 | Option Exercise | 25,000 | -- | -- | 44% 56.77K to 81.77K | |
| 31-Jan-23 9:51 PM View: | Rubius Therapeutics, Inc. (RUBY) | 31-Jan-23 | Option Sale | 7,240 | $0.24 | $1,744.84 | (9%) 81.77K to 74.53K | |
| 31-Jan-23 9:51 PM View: | Rubius Therapeutics, Inc. (RUBY) | 29-Jan-23 | Option Exercise | 21,250 | -- | -- | 60% 35.52K to 56.77K | |
| 01-Feb-22 9:20 PM View: | Rubius Therapeutics, Inc. (RUBY) | 01-Feb-22 | Option Sale | 6,730 | $6.57 | $44,236.30 | (16%) 42.25K to 35.52K | |
| 01-Feb-22 9:20 PM View: | Rubius Therapeutics, Inc. (RUBY) | 29-Jan-22 | Option Exercise | 21,250 | -- | -- | 101% 21.0K to 42.25K | |
| 14-Feb-22 10:00 PM View: | Rubius Therapeutics, Inc. (RUBY) | 16-Jun-21 | Gift | 2,200 | -- | -- | (7%) 31.52K to 29.32K | |
| 14-Feb-22 10:00 PM View: | Rubius Therapeutics, Inc. (RUBY) | 26-Apr-21 | Gift | 4,000 | -- | -- | (11%) 35.52K to 31.52K | |
| 15-Apr-20 5:14 PM View: | Rubius Therapeutics, Inc. (RUBY) | 14-Apr-20 | Market Purchase | 21,000 | $4.70 | $98,693.70 | 100% 0 to 21.0K | 205% |
| 21-Nov-19 4:07 PM View: | Crispr Therapeutics Ag (CRSP) | 19-Nov-19 | Option Exercise | 7,500 | $5.59 | $41,925.00 | 100% 0 to 7.5K | |
| 21-Nov-19 4:07 PM View: | Crispr Therapeutics Ag (CRSP) | 19-Nov-19 | Market Option Sale (Planned) | 7,500 | $62.00 | $465,000.00 | (100%) 7.5K to 0 | (179%) |
| 13-Nov-19 4:30 PM View: | Crispr Therapeutics Ag (CRSP) | 12-Nov-19 | Option Exercise | 7,500 | $5.59 | $41,925.00 | 100% 0 to 7.5K | |
| 13-Nov-19 4:30 PM View: | Crispr Therapeutics Ag (CRSP) | 12-Nov-19 | Market Option Sale (Planned) | 7,500 | $55.00 | $412,500.00 | (100%) 7.5K to 0 | (215%) |
| 01-Nov-19 6:35 PM View: | Crispr Therapeutics Ag (CRSP) | 30-Oct-19 | Option Exercise | 7,500 | $5.59 | $41,925.00 | 100% 0 to 7.5K | |
| 01-Nov-19 6:35 PM View: | Crispr Therapeutics Ag (CRSP) | 30-Oct-19 | Market Option Sale (Planned) | 7,500 | $52.00 | $390,000.00 | (100%) 7.5K to 0 | (233%) |
| 05-Jul-18 6:25 PM View: | Crispr Therapeutics Ag (CRSP) | 05-Jul-18 | Option Exercise | 1,684 | $5.59 | $9,413.56 | 100% 0 to 1.68K | |
| 05-Jul-18 6:25 PM View: | Crispr Therapeutics Ag (CRSP) | 05-Jul-18 | Market Option Sale (Planned) | 1,684 | $62.00 | $104,408.00 | (100%) 1.68K to 0 | (179%) |
| 05-Jul-18 6:25 PM View: | Crispr Therapeutics Ag (CRSP) | 03-Jul-18 | Option Exercise | 5,816 | $5.59 | $32,511.40 | 100% 0 to 5.82K | |
| 05-Jul-18 6:25 PM View: | Crispr Therapeutics Ag (CRSP) | 03-Jul-18 | Market Option Sale (Planned) | 5,816 | $62.00 | $360,592.00 | (100%) 5.82K to 0 | (179%) |
| 03-Oct-13 9:39 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 01-Oct-13 | Disposition | 16,257 | $125.00 | $2,032,120.00 | (100%) 16.26K to 0 | |
| 13-Mar-13 7:44 PM View: | Onyx Pharmaceuticals Inc. (ONXX) | 11-Mar-13 | Grant | 16,257 | -- | -- | 100% 0 to 16.26K | |
| 02-Oct-09 5:53 PM View: | Allos Therapeutics, Inc. (ALTH) | 30-Sep-09 | Disposition | 61,373 | -- | -- | (71%) 86.57K to 25.2K | |
| 20-Mar-09 4:58 PM View: | Allos Therapeutics, Inc. (ALTH) | 20-Mar-09 | Market Sale (Planned) | 6,200 | $6.63 | $41,078.70 | (7%) 92.77K to 86.57K | (18%) |
| 25-Feb-09 7:47 PM View: | Allos Therapeutics, Inc. (ALTH) | 23-Feb-09 | Grant | 23,873 | -- | -- | 35% 68.9K to 92.77K | |
| 20-Mar-08 6:06 PM View: | Allos Therapeutics, Inc. (ALTH) | 20-Mar-08 | Market Sale (Planned) | 6,100 | $5.29 | $32,270.00 | (8%) 75.0K to 68.9K | (48%) |
| 20-Mar-07 5:33 PM View: | Allos Therapeutics, Inc. (ALTH) | 19-Mar-07 | Grant | 75,000 | -- | -- | 100% 0 to 75.0K | |
| 15-Dec-06 10:54 AM View: | OSI Pharmaceuticals Inc. (OSIP) | 13-Dec-06 | Grant | 6,700 | -- | -- | 67000% 10 to 6.71K | |
| 13-Aug-04 12:35 PM View: | Allos Therapeutics, Inc. (ALTH) | 12-Aug-04 | Market Sale | 1,455 | $1.95 | $2,837.25 | (100%) 1.46K to 0 | (300%) |
| 02-Jul-04 12:11 PM View: | Allos Therapeutics, Inc. (ALTH) | 30-Jun-04 | Private Purchase | 1,455 | $1.91 | $2,782.69 | 100% 0 to 1.46K | |
| 18-May-04 10:00 PM View: | Allos Therapeutics, Inc. (ALTH) | 12-May-04 | Market Sale | 2,204 | $2.03 | $4,474.12 | (100%) 2.2K to 0 | (284%) |
| 02-Jan-04 10:00 PM View: | Allos Therapeutics, Inc. (ALTH) | 31-Dec-03 | Private Purchase | 1,045 | $2.48 | $2,593.69 | 90% 1.16K to 2.2K |